Adverum Biotechnologies to Host a Conference Call and Webcast to Report Second Quarter 2020 Financial Results and Provide Cor...
July 29 2020 - 4:05PM
Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene
therapy company targeting unmet medical needs in ocular and rare
diseases, today announced that it will host a conference call and
webcast on Monday, August 10, 2020 at 1:30 pm PT/4:30 pm ET to
report its second quarter 2020 financial results and provide a
corporate update.
The live webcast will be accessible under Events and
Presentations in the Investors section of the company's website. To
participate in the conference call, dial 1-855-327-6837 (domestic)
or 1-631-891-4304 (international) and refer to the “Adverum
Biotechnologies’ Conference Call.” It is recommended call
participants dial in 15 minutes in advance. The archived audio
webcast will be available on the Adverum website following the call
and will be available for 30 days.
About Adverum BiotechnologiesAdverum
Biotechnologies (Nasdaq: ADVM) is a clinical-stage gene therapy
company targeting unmet medical needs in serious ocular and rare
diseases. Adverum is advancing the clinical development of its
novel gene therapy candidate, ADVM-022, as a one-time, intravitreal
injection for the treatment of patients with wet age-related
macular degeneration and diabetic macular edema. For more
information, please visit www.adverum.com.
Investor and Media Inquiries:
Investors:Myesha LacyAdverum Biotechnologies,
Inc.mlacy@adverum.com1-650-649-1257
Media:Cherilyn Cecchini, M.D.LifeSci
Communicationsccecchini@lifescicomms.com1-646-876-5196
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Mar 2024 to Apr 2024
Adverum Biotechnologies (NASDAQ:ADVM)
Historical Stock Chart
From Apr 2023 to Apr 2024